跳至主要内容
临床试验/IRCT20211017052794N1
IRCT20211017052794N1尚未招募3 期

Evaluation of the effect of adding Trimetazidine to standard treatment of patients with Aluminum phosphide poisoning,referal to Loghman Hospital In Tehran? a pilot study on mortality

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Consumption of oral form of Aluminium phosphide and referrs to Loghman Hospital under 24 hours and the presence of symptoms consistent with poisoning
  • Positive silver nitrate test
  • Carbon monoxide levels above 10 in non-smokers

排除标准

  • Glomerular Filtration Rate(GFR) less than 30 (if available ),history of renal failure , history of liver failure , history of acute myocardial infarction, history of heart failure, history of congenital heart disease
  • Pregnancy and lactation
  • Refer to hospital after 24 hours

研究者

相似试验